Mastery EAQ Ch. 35

A  Minoxidil

B  Tamsulosin

C  Dutasteride

D  Stanozolol

A  Androgens

B  Topical peripheral vasodilators

C  5-Alpha reductase inhibitors

D  Alpha1-adrenergic blockers

A  Benign prostatic hyperplasia

B  Dysuria

C  Back pain

D  Gastrointestinal upset

A  Testosterone

B  Minoxidil

C  Goserelin

D  Doxazosin

A  Schedule II

B  Schedule III

C  Schedule IV

D  Schedule I

A  Tamsulosin

B  Finasteride

C  Doxazosin

D  Sildenafil

A  Hypertension

B  Baldness

C  Infertility

D  Benign prostate hyperplasia (BPH)

A  Depression

B  Loss of libido

C  Hypotension

D  Peliosis of the liver

A  Glucose

B  Hemoglobin

C  Hematocrit

D  Liver function

A  Renal calculi

B  Neurogenic bladder

C  Urinary tract infection

D  Benign prostatic hyperplasia

A  Anticoagulants

B  Alpha agonists

C  Antibiotics

D  Nitrates

A  White blood cell (WBC) count, Comprehensive metabolic panel

B  White blood cell (WBC) count, Blood glucose

C  Blood glucose, Comprehensive metabolic panel

D  Lipid panel, Liver function tests (LFTs)

A  “These drugs work together to shrink tissue in the prostate, relieving the obstruction.”

B  “Both medications have a rapid onset of action and work together to alleviate the obstruction.”

C  “Finasteride takes 6 months to work, whereas tamsulosin begins working immediately.”

D  “Tamsulosin alleviates the antiandrogen effects that are caused by finasteride.”

A  Dyspnea, Chest pain

B  Dizziness, Urinary frequency

C  Impotence, Urinary frequency

D  Impotence, Dizziness

A  Creatinine 2.5 mg/dL

B  Fasting blood glucose 110 mg/dL

C  Gastroesophageal reflux

D  Enlarged prostate

A  Can take medication twice daily

B  Report erections longer than 4 hours

C  Take drug 2 hours before sexual activity

D  Normal dose is 10 mg

A  Saw palmetto

B  Hydrochlorothiazide

C  Citalopram

D  Lisinopril

A  Anemia, Malabsorption syndrome

B  Infertility, Cardiovascular disorder

C  Muscle atrophy, Anemia

D  Muscle atrophy, Malabsorption syndrome

A  Increased hair growth, Reduction of prostate size

B  Impotence, Bradycardia

C  Bradycardia, Libido enhancement

D  Libido enhancement, Impotence

A  Perform a thorough history, including medication.

B  Instruct the patient to take all cardiac medications first.

C  Call the health care provider to change the prescription.

D  Assess the patient’s blood pressure.

A  A patient with AIDS

B  A patient with catabolism after major abdominal surgery

C  A high school athlete who has difficulty gaining weight

D  A patient with severe burns over 70% of the body

A  “I will push the suppository into my urethra.”

B  “I will take the tablet 1 hour before intercourse.”

C  “I will apply it to my abdomen.”

D  “I will apply it onto the scrotal skin.”

A  Obtain blood pressure

B  Calculate 24-hour output

C  Review liver function tests

D  Assess skin integrity

A  “Oral testosterone lasts no more than 12 hours.”

B  “Injectable testosterone has a longer duration of action.”

C  “Transdermal systems can be used but must be changed weekly.”

D  “Underarm spray form requires twice-daily application.”

A  Metformin

B  Isosorbide mononitrate

C  Atorvastatin

D  Finasteride

A  Helps in production of red blood cells, Helps in development of facial hair in men, Helps develop the male sex characteristics

B  Triggers better metabolic bodily functions, Triggers erectile dysfunction (ED), Helps in production of red blood cells

C  Triggers better metabolic bodily functions, Helps develop the male sex characteristics, Triggers erectile dysfunction (ED)

D  Helps in development of facial hair in men, Triggers better metabolic bodily functions, Triggers erectile dysfunction (ED)

A  Hypoglycemia, Liver disorders

B  Erectile dysfunction, Pulmonary hypertension

C  Hypothyroidism, Hypoglycemia

D  Liver disorders, Hypothyroidism

A  Oligospermia, Pregnancy, Hypogonadism

B  Oligospermia, Hypogonadism, Renal disease

C  Hepatic disease, Oligospermia, Hypogonadism

D  Pregnancy, Renal disease, Hepatic disease

A  The patient verbalizes the ability to maintain an erection.

B  The patient’s blood pressure is 90/60 mm Hg.

C  The patient does not have dry mouth, nausea, or vomiting.

D  The patient’s cardiac output is 5.6 L/min.

A  “Do not take the sildenafil.”

B  “Take the medications on opposite days.”

C  “Take your blood pressure before either medication.”

D  “Take the isosorbide mononitrate before the sildenafil.”

A  Bone development, Production of red blood cells, Development of secondary sexual characteristics

B  Excretion of sodium and potassium, Development of secondary sexual characteristics, Fat metabolism

C  Fat metabolism, Production of red blood cells, Excretion of sodium and potassium

D  Fat metabolism, Excretion of sodium and potassium, Bone development

A  Peliosis of the liver

B  Hirsutism

C  Fluid retention

D  Roundness of face

A  Hypoglycemia

B  Fatty liver

C  Anemia

D  Hyperacidity

A  Applies the patch on shaved skin

B  Applies the patch on clean, dry skin

C  Replaces the patch every other day

D  Applies the patch on the scrotum

A  Finasteride

B  Minoxidil

C  Tamsulosin

D  Stanozolol

A  Ultrasonography of the fetus

B  Liver function test

C  Exercise tolerance test

D  Lipid profile

A  Endometriosis, Refractory anemias

B  Priapism, Hypergonadism

C  Prostate cancer, Hypergonadism

D  Prostate cancer, Priapism

A  Metformin

B  Leuprolide

C  Doxycycline

D  Nitroglycerin

A  Muscle hypertrophy

B  Stress relief

C  Pain relief

D  Euphoric effect

A  Stronger urinary stream without hesitancy

B  Restoration of a full head of hair in 1 month

C  Weight gain of 1 to 2 pounds per week

D  Increase in libido

A  Back, Thighs, Shoulder

B  Back, Thighs, Abdomen

C  Back, Shoulder, Abdomen

D  Shoulder, Thighs, Abdomen

A  Those who do not socialize well

B  Those often tardy

C  High class performers

D  Team athletes

A  Continue to assess.

B  Call the health care provider.

C  Hold the medication.

D  Measure testosterone levels.

A  Causes hypotension if taken with nitroglycerin

B  Reduces the efficacy of nitroglycerin

C  Is contraindicated for use in elderly patients

D  May cause erectile dysfunction in patients

A  Decreased libido

B  Fluid retention

C  Prolonged erection

D  Increased amount of ejaculate

A  Abdomen

B  Upper arms

C  Thighs

D  Scrotum

A  Oral

B  Intramuscular

C  Transdermal

D  Topical

A  Sildenafil

B  Methyltestosterone

C  Finasteride

D  Minoxidil

A  Tachycardia

B  Changes in libido

C  Dermatitis

D  Chest pain

A  5 mg by mouth

B  25 to 100 mg 1 hour before intercourse

C  50 to 400 mg by intramuscular injection

D  1 mg by mouth

A  Testosterone

B  Finasteride

C  Minoxidil

D  Sildenafil

A  Relaxing urine retention

B  Reducing obstruction in the urethra

C  Increasing penile blood flow

D  Improving erectile dysfunction

A  Furosemide

B  Nitroglycerin

C  Famotidine

D  Ibuprofen

A  Relief from fluid retention

B  Enhancement of the male libido

C  Prolonged erection

D  Increased hair growth

A  Injection

B  Oral

C  Buccal

D  Transdermal

A  3 to 6 months

B  2 to 4 weeks

C  1 to 3 months

D  1 to 2 weeks

A  Nandrolone

B  Goserelin

C  Alfuzosin

D  Nilutamide